AllianceBernstein’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Hold
55,896
﹤0.01% 2226
2026
Q1
$1.47M Buy
55,896
+5,866
+12% +$139K ﹤0.01% 2162
2025
Q4
$1.32M Hold
50,030
﹤0.01% 2219
2025
Q3
$855K Hold
50,030
﹤0.01% 2416
2025
Q2
$628K Hold
50,030
﹤0.01% 2513
2025
Q1
$596K Hold
50,030
﹤0.01% 2484
2024
Q4
$732K Hold
50,030
﹤0.01% 2482
2024
Q3
$628K Hold
50,030
﹤0.01% 2554
2024
Q2
$426K Sell
50,030
-220
-0.4% -$1.96K ﹤0.01% 2750
2024
Q1
$529K Buy
50,250
+14,460
+40% +$161K ﹤0.01% 2566
2023
Q4
$372K Buy
35,790
+4,110
+13% +$32.8K ﹤0.01% 2749
2023
Q3
$201K Buy
31,680
+14,460
+84% +$107K ﹤0.01% 2959
2023
Q2
$149K Buy
+17,220
New +$154K ﹤0.01% 3033

Other funds holding ZYME

AllianceBernstein's ZYME Position: Q2 2026 in Review

AllianceBernstein held its Zymeworks (ZYME) position steady in Q2 2026 at 55,896 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

AllianceBernstein first reported a position in ZYME in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.47M in Q1 2026. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • AllianceBernstein held 55,896 shares of Zymeworks worth $1.4M as of Q2 2026.
  • AllianceBernstein left its Zymeworks share count unchanged in Q2 2026.
  • Zymeworks made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2226 holding.
  • AllianceBernstein first reported a position in Zymeworks in Q2 2023 and has held it in 13 quarters since.
  • AllianceBernstein's Zymeworks position peaked at $1.47M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.